Literature DB >> 11733953

Why study third-, fourth-, fifth-, ...line chemotherapy of ovarian cancer?

M Markman.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11733953     DOI： 10.1006/gyno.2001.6458

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  2 in total

1.  An Example of Ovarian Cancer as a 'Chronic Disease Process' - 11-Year Survival with Multiple Treatments for Recurrent and Progressive Disease.

Authors:  Maurie Markman; Vinay Malviya
Journal:  Case Rep Oncol       Date:  2008-10-17

Review 2.  Pharmaceutical management of ovarian cancer : current status.

Authors:  Maurie Markman
Journal:  Drugs       Date:  2008       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.